Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions

The 2019 coronavirus pandemic remains a major public health concern. Neutralizing antibodies (nAbs) represent a cutting-edge antiviral strategy. We focus here on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV, and discuss current progress in antibody research against rampa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trends Immunol
Autors principals: Gavor, Edem, Choong, Yeu Khai, Er, Shi Yin, Sivaraman, Hariharan, Sivaraman, J.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498231/
https://ncbi.nlm.nih.gov/pubmed/33041212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2020.09.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars